➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Mallinckrodt
Baxter
Moodys
Express Scripts

Last Updated: September 28, 2020

DrugPatentWatch Database Preview

Patent: 7,269,923

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,269,923
Title:Method of preparing Tricholoma matsutake-infected young pine by coculturing aseptic pine seedlings and T. matsutake
Abstract: Disclosed is a method of preparing Tricholoma matsutake-infected young pine trees by coculturing aseptic seedlings of a pine tree with a T. matsutake isolate, comprising the steps of liquid-culturing fruit bodies of naturally occurring matsutake mushrooms in PDB (Potatto Dextrose Broth, Difco) and inoculating T. matsutake KBFERI 20T05 isolated from the cultured fruit bodies; placing mixed soil of perlite and sphagnum peatmoss and K-liquid medium onto the inoculated fungus; and planting aseptic seedlings obtained by aseptically germinating pine seeds into the mixed soil, and then culturing the pine seedlings with the T. matsutake isolate to allow ectomycorrhiza formation on the fine roots of the pine seedlings. The method of the present invention is advantageous in terms of giving objectivity for the fungal inoculum by employing as an inoculum a fungus having DNA homology with the conventionally known T. matsutake, and of making it possible to mass produce T. matsutake-infected pine trees throughout the Year.
Inventor(s): Park; Moo-Chang (Daegu-si, KR), Sim; Sang-Gab (Gyeongju-si, KR), Cheon; Woo-Jae (Pohang-si, KR)
Assignee: Govenor of Gyeongsangbukdo (Daegu-si, KR)
Application Number:10/656,496
Patent Claims:see list of patent claims

Details for Patent 7,269,923

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial Govenor of Gyeongsangbukdo (Daegu-si, KR) 2022-09-06 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial Govenor of Gyeongsangbukdo (Daegu-si, KR) 2022-09-06 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Moodys
Colorcon
Johnson and Johnson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.